RCMI representatives participated in the Beijing- Baoding study tour coordinated by The Modernized Chinese Medicine International Association (MCMIA).
Their visit to the National Medical Products Administration (NMPA) provided invaluable insights into China's pharmaceutical regulatory landscape, the evolution of traditional Chinese medicine (TCM), and emerging trends in the health and nutrition sector.
Through meaningful dialogues with industry leaders and scholars, they profoundly impacted the trajectory of their research endeavors.
Their visit to the National Medical Products Administration (NMPA) provided invaluable insights into China's pharmaceutical regulatory landscape, the evolution of traditional Chinese medicine (TCM), and emerging trends in the health and nutrition sector.
Through meaningful dialogues with industry leaders and scholars, they profoundly impacted the trajectory of their research endeavors.
